Bacchus Bio innovation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bacchus Bio innovation - overview
Established
2020
Location
Kobe-shi, Hyogo, Japan
Primary Industry
Biotechnology
About
Based in Japan, and founded in 2020, Bacchus Bio innovation Co. , Ltd. operates as a biofoundry company that develops biotechnology such as cells of plants, animals, and microorganisms to produce useful substances. In October 2025, Bacchus Bio innovation Co.
, Ltd. raised an undisclosed amount in venture funding from Mizuho Bank. Bacchus Bio Innovation Co. , Ltd.
transfers advanced biotechnology-related technologies and perform contract services related to the production of useful substances by microorganisms and the development of products, providing medical professionals with a smart and digital health system. The company plans to use the October 2025 funds to further improve its technological expertise and industry knowledge in biomanufacturing, while also advancing initiatives to broaden the bioeconomy market and achieve a sustainable society.
Current Investors
Sojitz Corporation, Shimadzu Corporation, Idemitsu Kosan
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics
Website
www.b2i.co.jp
Verticals
Artificial Intelligence, Big Data, Robotics
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.